Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
7.68
-0.69 (-8.24%)
At close: Aug 28, 2026, 4:00 PM EDT
7.79
+0.11 (1.40%)
After-hours: Aug 28, 2026, 7:46 PM EDT
MRVI Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 208.78 | 185.74 | 259.19 | 288.95 | 883 | 799.24 | |
Revenue Growth | -5.03% | -28.34% | -10.30% | -67.28% | 10.48% | 181.32% |
Cost of Revenue | 134.23 | 150.05 | 150.88 | 148.74 | 168.96 | 140.56 |
Gross Profit | 74.55 | 35.69 | 108.31 | 140.2 | 714.04 | 658.68 |
Selling, General & Admin | 127.85 | 143.92 | 161.77 | 151.39 | 125.76 | 100.06 |
Research & Development | 15.22 | 17.4 | 19.22 | 17.28 | 18.37 | 15.22 |
Operating Expenses | 143.08 | 161.32 | 180.99 | 168.67 | 144.13 | 115.28 |
Operating Income | -68.53 | -125.63 | -72.68 | -28.47 | 569.92 | 543.4 |
Interest Expense | -23.96 | -26.99 | -47.7 | -45.89 | -20.41 | -30.26 |
Interest & Investment Income | 8.21 | 11.44 | 27.4 | 27.73 | 2.34 | - |
Other Non Operating Income (Expenses) | -0.26 | -4.15 | -2.38 | 667.55 | -4.46 | 6.38 |
EBT Excluding Unusual Items | -84.53 | -145.34 | -95.36 | 620.92 | 547.38 | 519.52 |
Merger & Restructuring Charges | -23.57 | -20.73 | 1.21 | -6.47 | -3.5 | - |
Impairment of Goodwill | - | -42.88 | -166.1 | - | - | - |
Gain (Loss) on Sale of Assets | - | - | - | - | - | 11.25 |
Asset Writedown | -24.77 | -25.83 | -0.05 | - | - | - |
Other Unusual Items | -3.61 | -0.2 | -1.18 | 3.29 | 7.59 | - |
Pretax Income | -136.49 | -234.97 | -261.48 | 617.74 | 551.47 | 530.77 |
Income Tax Expense | -0.41 | -4.21 | -1.86 | 756.11 | 60.81 | 61.52 |
Earnings From Continuing Operations | -136.08 | -230.76 | -259.62 | -138.38 | 490.66 | 469.25 |
Minority Interest in Earnings | 58.69 | 99.99 | 114.78 | 19.35 | -270.46 | -287.21 |
Net Income | -77.39 | -130.77 | -144.85 | -119.03 | 220.21 | 182.04 |
Net Income to Common | -77.39 | -130.77 | -144.85 | -119.03 | 220.21 | 182.04 |
Net Income Growth | - | - | - | - | 20.97% | 136.76% |
Shares Outstanding (Basic) | 146 | 144 | 138 | 132 | 132 | 115 |
Shares Outstanding (Diluted) | 146 | 144 | 138 | 132 | 255 | 258 |
Shares Change | 2.29% | 4.68% | 4.54% | -48.33% | -0.96% | 791.80% |
EPS (Basic) | -0.53 | -0.91 | -1.05 | -0.90 | 1.67 | 1.59 |
EPS (Diluted) | -0.53 | -0.91 | -1.05 | -0.90 | 1.67 | 1.56 |
EPS Growth | - | - | - | - | 6.97% | -33.73% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -35.84 | -70.72 | -22.19 | 60.67 | 518.89 | 353.72 |
Free Cash Flow Per Share | -0.24 | -0.49 | -0.16 | 0.46 | 2.03 | 1.37 |
Gross Margin | 35.71% | 19.21% | 41.79% | 48.52% | 80.87% | 82.41% |
Operating Margin | -32.82% | -67.64% | -28.04% | -9.85% | 64.54% | 67.99% |
Profit Margin | -37.07% | -70.41% | -55.88% | -41.19% | 24.94% | 22.78% |
Free Cash Flow Margin | -17.17% | -38.07% | -8.56% | 21.00% | 58.76% | 44.26% |
EBITDA | -19.75 | -74.12 | -24.3 | 11.79 | 601.75 | 568.15 |
EBITDA Margin | -9.46% | -39.91% | -9.38% | 4.08% | 68.15% | 71.09% |
D&A For EBITDA | 48.78 | 51.51 | 48.38 | 40.25 | 31.84 | 24.75 |
EBIT | -68.53 | -125.63 | -72.68 | -28.47 | 569.92 | 543.4 |
EBIT Margin | -32.82% | -67.64% | -28.04% | -9.85% | 64.54% | 67.99% |
Effective Tax Rate | - | - | - | 122.40% | 11.03% | 11.59% |
Advertising Expenses | - | 4.2 | 3.5 | 2.9 | 2.5 | 1.3 |